The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Risk of Switch in Mood Polarity to Hypomania or Mania in Patients With Bipolar Depression During Acute and Continuation Trials of Venlafaxine, Sertraline, and Bupropion as Adjuncts to Mood Stabilizers
Open accessAbstract
OBJECTIVE: The authors examined the comparative risks of switches in mood polarity into hypomania or mania during acute and continuation trials of adjunctive antidepressant treatment of bipolar depression. METHOD: One hundred fifty-nine patients with bipolar I disorder or bipolar II disorder participated in a total of 228 acute (10-week) randomized trials of bupropion, sertraline, or venlafaxine as an adjunct to a mood stabilizer. Patients in 87 of these trials entered continuation treatment for up to 1 year. Antidepressant response and the occurrence of subthreshold brief hypomania (emergence of brief hypomania [at least 1 but <7 days] or recurrent brief hypomania) and threshold switches (emergence of full-duration hypomania [> or =7 days] or mania) were blindly assessed by using clinician-rated daily reports of mood-associated dysfunction on the National Institute of Mental Health Life Chart Method. RESULTS: Threshold switches into full-duration hypomania and mania occurred in 11.4% and 7.9%, respectively, of the acute treatment trials and in 21.8% and 14.9%, respectively, of the continuation trials. The rate of threshold switches was higher in the 169 trials in patients with bipolar I disorder (30.8%) than the 59 trials in patients with bipolar II disorder (18.6%). The ratio of threshold switches to subthreshold brief hypomanias was higher in both the acute (ratio=3.60) and continuation trials (ratio=3.75) of venlafaxine than in the acute and continuation trials of bupropion (ratios=0.85 and 1.17, respectively) and sertraline (ratios=1.67 and 1.66, respectively). In only 37 (16.2%) of the original 228 acute antidepressant trials, or in only 23.3% of the patients, was there a sustained antidepressant response in the continuation phase in the absence of a threshold switch. CONCLUSIONS: Adjunctive treatment with antidepressants in bipolar depression was associated with substantial risks of threshold switches to full-duration hypomania or mania in both acute and long-term continuation treatment. Of the three antidepressants included in the study, venlafaxine was associated with the highest relative risk of such switching and bupropion with the lowest risk.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Long-term Natural History of the Weekly Symptomatic Status of Bipolar I Disorder
Judd, L. L., Akiskal, H. S., Schettler, P. J., Endicott, J., Maser, J., Solomon, D. A., Leon, A. C., Rice, J. A., & Keller, M. B. (2002) · Archives of General Psychiatry · doi:10.1001/archpsyc.59.6.530 · Cited by 2,106
Calabrese, J. R., Bowden, C. L., Sachs, G. S., Ascher, J. A., Monaghan, E., Rudd, G. D., & The Lamictal 602 Study Group (1999) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v60n0203 · Cited by 1,054
Tohen, M., Vieta, E., Calabrese, J., Ketter, T. A., Sachs, G., Bowden, C., Mitchell, P. B., Centorrino, F., Risser, R., Baker, R. W., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.11.1079 · Cited by 908
Calabrese, J. R., Keck, P. E., Macfadden, W., Minkwitz, M., Ketter, T. A., Weisler, R. H., Cutler, A. J., McCoy, R., Wilson, E., Mullen, J., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1351 · Cited by 883
Self-citationCalabrese, J. R., Bowden, C. L., Sachs, G., Yatham, L. N., Behnke, K., Mehtonen, O.-P., Montgomery, P., Ascher, J., Paska, W., Earl, N., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0906 · Cited by 635
Antidepressant-induced mania and cycle acceleration: a controversy revisited
(1995) · American Journal of Psychiatry · doi:10.1176/ajp.152.8.1130 · Cited by 608
Antidepressants for Bipolar Depression: A Systematic Review of Randomized, Controlled Trials
Gijsman, H. J., Geddes, J. R., Rendell, J. M., Nolen, W. A., & Goodwin, G. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.9.1537 · Cited by 563
Self-citationPost, R. M., Denicoff, K. D., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Rush, A. J., Keck, P. E., McElroy, S. L., Luckenbaugh, D. A., et al. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0610 · Cited by 418
Self-citationCan antidepressants cause mania and worsen the course of affective illness?
(1987) · American Journal of Psychiatry · doi:10.1176/ajp.144.11.1403 · Cited by 398
Altshuler, L., Suppes, T., Black, D., Nolen, W. A., Keck, P. E., Frye, M. A., McElroy, S., Kupka, R., Grunze, H., Walden, J., et al. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.7.1252 · Cited by 287
Self-citationA double-blind trial of bupropion versus desipramine for bipolar depression.
Sachs, G. S., Lafer, B., Stoll, A. L., Banov, M. D., Thibault, A., Tohen, M. F., & Rosenbaum, J. F. (1994) · PubMed · Cited by 272
Antidepressant Treatment in Bipolar Versus Unipolar Depression
Ghaemi, S. N., Rosenquist, K. J., Ko, J. Y., Baldassano, C. F., Kontos, N. J., & Baldessarini, R. J. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.163 · Cited by 270
Vieta, E., Martinez-Aran, A., Goikolea, J. M., Torrent, C., Colom, F., Benabarre, A., & Reinares, M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n0607 · Cited by 227
Young, L. T., Joffe, R. T., Robb, J. C., MacQueen, G. M., Marriott, M., & Patelis-Siotis, I. (2000) · American Journal of Psychiatry · doi:10.1176/ajp.157.1.124 · Cited by 211
DENICOFF, K. D., LEVERICH, G. S., NOLEN, W. A., RUSH, A. J., McELROY, S. L., KECK, P. E., SUPPES, T., ALTSHULER, L. L., KUPKA, R., FRYE, M. A., et al. (2000) · Psychological Medicine · doi:10.1017/s0033291799002810 · Cited by 188
Self-citationThe Stanley Foundation Bipolar Treatment Outcome Network
Leverich, G. S., Nolen, W. A., Rush, A. J., McElroy, S. L., Keck, P. E., Denicoff, K. D., Suppes, T., Altshuler, L. L., Kupka, R., Kramlinger, K. G., et al. (2001) · Journal of Affective Disorders · doi:10.1016/s0165-0327(01)00430-x · Cited by 185
Self-citationKupka, R. W., Luckenbaugh, D. A., Post, R. M., Suppes, T., Altshuler, L. L., Keck, P. E., Frye, M. A., Denicoff, K. D., Grunze, H., Leverich, G. S., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.7.1273 · Cited by 171
Self-citationRapid and Non-Rapid Cycling Bipolar Disorder: A Meta-Analysis of Clinical Studies
Kupka, R. W., Luckenbaugh, D. A., Post, R. M., Leverich, G. S., & Nolen, W. A. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1213 · Cited by 168
Self-citationNolen, W. A., Luckenbaugh, D. A., Altshuler, L. L., Suppes, T. M., McElroy, S. L., Frye, M. A., Kupka, R., Keck, P. E., Leverich, G. S., & Post, R. M. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.8.1447 · Cited by 159
Self-citationPost, R. M., Leverich, G. S., Nolen, W. A., Kupka, R., Altshuler, L. L., Frye, M. A., Suppes, T. M., McElroy, S. L., Keck, P. E., Grunze, H., et al. (2003) · Bipolar Disorders · doi:10.1046/j.1399-5618.2003.00065.x · Cited by 154
Self-citationAn overview of recent findings of the Stanley Foundation Bipolar Network (Part I)
Post, R. M., Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T. M., Keck, P. E., McElroy, S. L., Kupka, R., Nolen, W. A., Grunze, H., et al. (2003) · Bipolar Disorders · doi:10.1034/j.1399-5618.2003.00051.x · Cited by 154
Self-citationPost, R. M., Altshuler, L. L., Frye, M. A., Suppes, T. M., Rush, A. J., Keck, P. E., McElroy, S. L., Denicoff, K. D., Leverich, G. S., Kupka, R., et al. (2001) · Bipolar Disorders · doi:10.1034/j.1399-5618.2001.030505.x · Cited by 139
Self-citationAltshuler, L. L., Kiriakos, L., Calcagno, J. L., Goodman, R., Gitlin, M. J., Frye, M. A., & Mintz, J. (2001) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v62n0807 · Cited by 127
Self-citationThe Stanley Foundation Bipolar Network: 1. Rationale and methods
Post, R. M., Denicoff, K. D., Leverich, G. S., Nolen, W. A., Kupka, R., Keck, P. E., McElroy, S. L., Rush, A. J., Suppes, T. M., Altshuler, L. L., et al. (2001) · The British Journal of Psychiatry · doi:10.1192/bjp.178.41.s169 · Cited by 120
Self-citationDenicoff, K. D., Smith‐Jackson, E. E., Disney, E. R., Suddath, R. L., Leverich, G. S., & Post, R. M. (1997) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(96)00027-1 · Cited by 106
Self-citationInternational Consensus Group on Bipolar I Depression Treatment Guidelines
Calabrese, J. R., Kasper, S. F., Johnson, G., Tajima, O., Yatham, L. N., & Young, A. H. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0419 · Cited by 100
Life Charting of Affective Disorders
Leverich, G. S., & Post, R. M. (1998) · CNS Spectrums · doi:10.1017/s1092852900031138 · Cited by 99
Self-citationBupropion as a promising approach to rapid cycling bipolar II patients.
Haykal, R. F., & Akiskal, H. S. (1990) · PubMed · Cited by 95
The treatment of bipolar depression.
Compton, M. T., & Nemeroff, C. B. (2000) · PubMed · Cited by 94
Quetiapine in the treatment of rapid cycling bipolar disorder
Vieta, E., Parramón, G., Padrell, E., Nieto, E., Martínez‐Arán, A., Corbella, B., Colom, F., Reinares, M., Goikolea, J. M., & Torrent, C. (2002) · Bipolar Disorders · doi:10.1034/j.1399-5618.2002.01204.x · Cited by 92
Controlled trials in bipolar I depression: focus on switch rates and efficacy
Calabrese, J. R., RAPPORT, D. J., Kimmel, S. E., & Shelton, M. D. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(99)00023-1 · Cited by 73
The role of atypical antipsychotics in bipolar depression and anxiety disorders
McIntyre, R. S., & Katzman, M. A. (2003) · Bipolar Disorders · doi:10.1111/j.1399-2406.2003.00061.x · Cited by 59
Post, R. M. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.4.531 · Cited by 11
Self-citation
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Beaulieu, S., Alda, M., O’Donovan, C., MacQueen, G., McIntyre, R. S., Sharma, V., et al. (2013) · Bipolar Disorders · doi:10.1111/bdi.12025 · Cited by 1,217
Self-citationEffectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression
Sachs, G. S., Nierenberg, A. A., Calabrese, J. R., Marangell, L. B., Wisniewski, S. R., Gyulai, L., Friedman, E. S., Bowden, C. L., Fossey, M. D., Ostacher, M. J., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa064135 · Cited by 937
Malhi, G. S., Bassett, D., Boyce, P., Bryant, R., Fitzgerald, P. B., Fritz, K., Hopwood, M., Lyndon, B., Mulder, R., Murray, G., et al. (2015) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415617657 · Cited by 842
“CBR Australian & New Zealand Journal of Psychiatry, 49(12) (Gijsman et al., 2004; Leverich et al., 2006; Nemeroff et al., 2001; Peet, 1994; Post et al., 2006; Sachs et al., 1994; Vieta et al., 2002).”
BackgroundPacchiarotti, I., Bond, D. J., Baldessarini, R. J., Nolen, W. A., Grunze, H., Licht, R. W., Post, R. M., Berk, M., Goodwin, G. M., Sachs, G. S., et al. (2013) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2013.13020185 · Cited by 770
Self-citationThase, M. E., Macfadden, W., Weisler, R. H., Chang, W., Paulsson, B., Khan, A., & Calabrese, J. R. (2006) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000248603.76231.b7 · Cited by 559
Metadata
- Authors
- Leverich, G. S., Altshuler, L. L., Frye, M. A., Suppes, T., McElroy, S. L., Keck, P. E., Kupka, R. W., Denicoff, K. D., Nolen, W. A., Grunze, H., Martinez, M. I., & Post, R. M.
- Venue
- American Journal of Psychiatry
- Published
- 2006-02-01
- Volume
- 163
- Issue
- 2
- Pages
- 232-239
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2129604620
- Cited by
- 419
- References
- 33
- FWCI
- 26.25
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.